Elevance Health Inc. (NYSE:ELV)

The financial information indicates a consistent, though decelerating, trend in both net cash provided by operating activities and free cash flow to the firm (FCFF) over the five-year period. Both metrics demonstrate a decline from 2021 to 2025.

Net Cash from Operations

Net cash provided by operating activities began at US$8,364 million in 2021 and experienced a modest increase to US$8,399 million in 2022. However, subsequent years show a decreasing pattern, falling to US$8,061 million in 2023, US$5,808 million in 2024, and further to US$4,290 million in 2025. This represents an overall decrease of approximately 48.6% from 2021 to 2025.

Free Cash Flow to the Firm (FCFF)

FCFF mirrored the trend observed in operating cash flow. Starting at US$7,909 million in 2021, it rose slightly to US$7,927 million in 2022. A decline then commenced, with FCFF reaching US$7,567 million in 2023, US$5,487 million in 2024, and US$4,364 million in 2025. This signifies a total reduction of approximately 44.8% from 2021 to 2025. The decrease in FCFF is proportionally similar to the decrease in operating cash flow, suggesting that changes in operating activities are a primary driver of the FCFF trend.

The consistent decline in both metrics warrants further investigation to determine the underlying causes. Potential factors could include changes in revenue, operating expenses, working capital management, or capital expenditures. The rate of decline appears to be accelerating in the later years of the period, particularly from 2023 to 2025, which may indicate emerging challenges to cash generation.

Interest paid, net of tax, demonstrates a consistent upward trend over the five-year period. Simultaneously, the effective income tax rate exhibits fluctuations. An examination of these figures reveals potential relationships and areas for further investigation.

Interest Paid, Net of Tax

Interest paid, net of tax, increased from US$632 million in 2021 to US$1,190 million in 2025. This represents a cumulative increase of 88.3% over the period. The growth was not linear; increases from 2021 to 2022 and 2022 to 2023 were approximately 7.6% and 17.9% respectively. The rate of increase accelerated between 2023 and 2024 (16.7%) and again between 2024 and 2025 (27.3%). This accelerating growth warrants further scrutiny to understand the underlying drivers, such as changes in debt levels, interest rates, or debt composition.

Effective Income Tax Rate

The effective income tax rate experienced variability throughout the period. It decreased from 23.10% in 2021 to 22.30% in 2023, before increasing to 24.50% in 2024. A significant decrease is then observed in 2025, falling to 15.60%. This substantial decline in the effective income tax rate in the final year could be attributable to various factors, including changes in tax legislation, the geographic distribution of profits, or the realization of tax credits or benefits. The fluctuations suggest potential changes in the company’s tax planning strategies or operating environment.

Relationship between Interest Paid and Effective Income Tax Rate

While interest paid consistently increased, the effective income tax rate fluctuated. The decrease in the effective income tax rate in 2025 coincided with the largest absolute increase in interest paid. It is important to determine if these changes are correlated. A lower effective income tax rate, while beneficial to net income, may not fully offset the increased expense of interest, particularly as interest payments continue to rise. Further analysis is needed to assess the net impact on profitability and cash flow.

The observed trends suggest a growing interest expense coupled with a volatile tax rate. A comprehensive review of the company’s debt structure, financing activities, and tax position is recommended to fully understand the implications of these changes.

The Enterprise Value to Free Cash Flow to the Firm (EV/FCFF) ratio exhibits a consistent upward trend over the observed five-year period. Enterprise Value demonstrates an initial increase from 2021 to 2023, followed by declines in 2024 and 2025. Simultaneously, Free Cash Flow to the Firm (FCFF) experiences a gradual decrease throughout the entire period.

Enterprise Value

Enterprise Value increased from US$100,728 million in 2021 to US$107,367 million in 2023, representing a growth of approximately 6.5%. However, subsequent years show a decline, falling to US$85,443 million in 2024 and further to US$70,889 million in 2025. This represents a total decrease of approximately 30.1% from the peak in 2023.

Free Cash Flow to the Firm (FCFF)

Free Cash Flow to the Firm (FCFF) decreased steadily throughout the period. Starting at US$7,909 million in 2021, it declined to US$7,567 million in 2023, and continued to fall to US$5,487 million in 2024 and US$4,364 million in 2025. This represents a total decrease of approximately 44.8% from 2021 to 2025.

EV/FCFF Ratio

The EV/FCFF ratio increased consistently from 12.74 in 2021 to 16.24 in 2025. This increase is driven by the combination of a relatively stable, then declining Enterprise Value and a consistently decreasing Free Cash Flow to the Firm. The ratio’s increase suggests that the market is valuing each dollar of free cash flow at a higher multiple over time. The most significant increase occurred between 2023 and 2025, rising from 14.19 to 16.24.

The observed trends suggest a potential shift in market perception regarding the company’s ability to generate future cash flow relative to its overall value. The increasing EV/FCFF ratio, coupled with declining FCFF, warrants further investigation into the underlying drivers of these changes.